Celine Halioua, CEO of Loyal developing drugs to extend dog lifespans, discusses developing drugs for dogs as a model for life extension in humans, genetic issues in dog breeds, the potential profitability of developing life extension drugs for dogs, and the power of the placebo effect in drug trials.

Celine Halioua, CEO of Loyal, discusses developing longevity drugs for dogs and potentially humans. Topics include FDA approval process, differences between biotech and software startups, mistakes as a founder, growth rate in hiring, and starting with dogs for drug development.

Celine Halioua, Founder/CEO of Loyal, announced FDA approval for a drug that can extend lifespan, a groundbreaking milestone in longevity biotech. The podcast explores the pursuit of immortality, targeting root causes of aging, challenges in aging research, and a young female founder's experience in the biotech industry.